6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine has been researched along with Antibody Deficiency Syndrome in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ammann, S; Brandau, H; Bredius, R; Burns, SO; Dückers, G; Edgar, JD; Ehl, S; Elling, R; Gyrd-Hansen, M; Hasselblatt, P; Schwarz, K; Speckmann, C; Warnatz, K; Worth, A; Zur Stadt, U | 1 |
1 other study(ies) available for 6-o-stearoyl-n-acetylmuramyl-alanylisoglutamine and Antibody Deficiency Syndrome
Article | Year |
---|---|
A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency.
Topics: Acetylmuramyl-Alanyl-Isoglutamine; Adolescent; Adult; Aged; Case-Control Studies; Child; Child, Preschool; Female; Flow Cytometry; Humans; Immunologic Deficiency Syndromes; Immunophenotyping; Infant; Leukocytes, Mononuclear; Male; Middle Aged; Mutation; Nod2 Signaling Adaptor Protein; Phenotype; T-Lymphocytes; Tumor Necrosis Factors; X-Linked Inhibitor of Apoptosis Protein; Young Adult | 2014 |